key: cord-0919256-1vgqcnh9
authors: Joseph, Maria; Gaszynski, Rafael; Bender, Kyle; Daly, Daniel; Merrett, Neil; Apostolou, Christos
title: How to perform transcystic stenting in the COVID‐19 pandemic: an approach to biliary stenting without specialized endobiliary stenting equipment
date: 2021-03-15
journal: ANZ J Surg
DOI: 10.1111/ans.16727
sha: 51e63bf897baaba285855e97ff4eeabfb2386f9a
doc_id: 919256
cord_uid: 1vgqcnh9

Management options for common bile duct stones found at laparoscopic cholecystectomy (LC) includes concurrent transcystic biliary stenting, effectively providing a conduit for common bile duct drainage and improving the success of subsequent endoscopic retrograde cholangiopancreatography. In the unprecedented COVID‐19 pandemic however, potential disruptions to the medical supply chain have been far reaching, including the distribution of specialised biliary stent sets. To overcome this, we devised an innovative method at our centre to substitute traditional procedural stent sets by employing standard, universally accessible open‐ended ureteral catheters, jagwires and pancreatic or biliary stents with similar procedural success.[Image: see text]

(a) Operative layout: This layout optimizes view and minimizes unnecessary movement. The X-ray screen and laparoscopic instruments are concurrently in full view of the primary operator. The radiographer also has sufficient space beside the C-arm for its manipulation as required. (b) In the absence of formal endobiliary stent sets, we employed a combination of a 5 French ureteral catheter, used as a pusher, 5-French 5 cm or 7 cm pancreatic stent and soft tipped hydrophilic jagwire. (c) Disposable Reddick-Olsen forcep. (d) Intraoperative cholangiogram; following deployment of the stent, the intraoperative cholangiogram confirms correct CBD stent positioning by a contrast visualization within duodenum and by thick radio-opaque pancreatic stent marker 2-3 cm distal to ampulla.

The screen is in full view of the primary operator, who is positioned on the patient's left (Fig. 1a) . Lead is worn to ensure radiation protection.

Using the standard laparoscopic technique, the cystic duct is identified with the critical view of safety, incised transversely and milked to remove in situ stones. The cystic duct is cannulated with a 5 French ureteric catheter introduced using either Reddick-Olsen forceps ( Fig. 1c) or Concord needle. The catheter is flushed with saline, followed by urograffin to delineate the biliary anatomy, including the length and tortuosity of the CBD, location of the ampulla and presence of stones. 3 The catheter is carefully advanced through the cystic duct into the CBD and eventually, via the ampulla into the duodenal lumen. If resistance is met, an over-the-wire method is employed, using a 260 cm straight soft-tip ERCP hydrophilic jag wire. The wire is guided through the catheter and advanced at least 40 cm from the cystic duct into the duodenal lumen under fluoroscopic guidance. Adequate wire length within the duodenal lumen is critical to reduce the risk of duodenal perforation by ensuring the stent passively feeds downwards along the duodenal lumen rather than transversely into the duodenal wall. The ureteric catheter is then removed.

In place of specialized endobiliary stents, we utilize standard pancreatic stents. A 5-French 5 or 7 cm single pigtail pancreatic stent is loaded onto the wire, with the flanged end orientated distally (Fig. 1b) . We found greater procedural success with the deployment of the 5 cm rather than 7 cm pancreatic stent as there is more structural integrity and manoeuvrability. The stent is advanced using the ureteral catheter as a 'pusher' (Fig. 1c) . At this time, the surgeon uses one hand to retract the wire and the other hand to advance the stent into the cystic duct and through the ampulla under laparoscopic vision. Fluoroscopy is used to confirm that the single radio-opaque marker is positioned within the CBD, approximately 2 cm proximal to the ampulla. When the surgeon is satisfied with the stent's positioning, the wire can be removed. Contrast is injected via the pusher to confirm adequate contrast entry into the duodenum and visualization of the stent 2-3 cm within the duodenal lumen (Fig. 1d ). 2 The ureteral catheter is then removed. Transcystic stenting is now complete, allowing for cystic duct ligation and completion of the cholecystectomy. ERCP and stone removal can subsequently be planned as a separate procedure.

In this article, we have described the operative layout, procedural equipment and technical steps required to perform transcystic stenting with universally accessible equipment. This may be adapted in future disaster situations or circumstances where supply is compromised.

This study has employed TGA approved surgical equipment utilized for human patients and was formulated in accordance with ethical standards outlined in the Declaration of Helsinki (revised Brazil 2013). 

Laparoscopic transcystic bile duct stenting in the management of common bile duct stones

At the epicenter of COVID-19 -the tragic failure of the global supply chain for medical supplies

Laparoscopic transcystic stenting and postoperative ERCP for the management of common bile duct stones at laparoscopic cholecystectomy